Miroslav Malešević
- Molecular Biology top 10%
- Infectious Diseases top 10%
- Immunology
- Oncology
- Cardiology and Cardiovascular Medicine
- Co-authors
- Günter FischerNorbert SewaldCordelia Schiene‐FischerUlf StrijowskiGunter FischerErik PrellBrigitte von BrunnYue Ma‐Lauer
- Topics
- Signaling Pathways in Disease (27 papers)Peptidase Inhibition and Analysis (6 papers)Chemical Synthesis and Analysis (6 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryAngewandte Chemie International Edition
- Partner nations
- GermanyUnited StatesCroatia
In The Last Decade
Miroslav Malešević
48 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 742
- Infectious Diseases 182
- Immunology 166
- Oncology 157
- Cardiology and Cardiovascular Medicine 125
Countries citing papers authored by Miroslav Malešević
This map shows the geographic impact of Miroslav Malešević's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miroslav Malešević with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miroslav Malešević more than expected).
Fields of papers citing papers by Miroslav Malešević
This network shows the impact of papers produced by Miroslav Malešević. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miroslav Malešević. The network helps show where Miroslav Malešević may publish in the future.
Co-authorship network of co-authors of Miroslav Malešević
This figure shows the co-authorship network connecting the top 25 collaborators of Miroslav Malešević. A scholar is included among the top collaborators of Miroslav Malešević based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miroslav Malešević. Miroslav Malešević is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 16 | |
| 3 | 51 | |
| 4 | 35 | |
| 5 | 12 | |
| 6 | 34 | |
| 7 | 107 | |
| 8 | 6 | |
| 9 | 15 | |
| 10 | 9 | |
| 11 | 14 | |
| 12 | 37 | |
| 13 | 51 | |
| 14 | 15 | |
| 15 | 60 | |
| 16 | 12 | |
| 17 | 31 | |
| 18 | 76 | |
| 19 | 6 | |
| 20 | Synthesis of New Heteropolycyclic Bis-Carboxamide: 3,5-Dichloro- N , N ’( p -Chlorophenyl)dithieno [3,2-b:2’,3’-d]Furan-2,6-Carboxamide | 4 |
About Miroslav Malešević
Miroslav Malešević is a scholar working on Molecular Biology, Immunology and Allergy and Immunology, having authored 49 papers that have together received 1.1k indexed citations. Recurring topics across this work include Signaling Pathways in Disease (27 papers), Peptidase Inhibition and Analysis (6 papers) and Chemical Synthesis and Analysis (6 papers). The work is most often cited by research in Molecular Biology (742 citations), Infectious Diseases (182 citations) and Immunology and Allergy (48 citations). Miroslav Malešević has collaborated with scholars based in Germany, United States and Croatia. Frequent co-authors include Günter Fischer, Norbert Sewald, Cordelia Schiene‐Fischer, Ulf Strijowski, Gunter Fischer, Erik Prell, Brigitte von Brunn, Yue Ma‐Lauer, Albrecht von Brunn and Michael Bukrinsky. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.